Hat mitgewirkt an:
-
Analyse von Veränderungen in der Transkription des tumor susceptibility gene TSG101 und eines neu identifizierten humanen Paralogen, UEV3, in klinischen Proben epithelialer und mesenchymaler Tumoren
-
The pathogenesis of microsatellite unstable colorectal cancer and the evaluation of novel diagnostic and therapeutic options
-
Report of the sixth meeting of the European Consortium ‘Care for CMMRD’ (C4CMMRD), Paris, France, November 16th 2022
-
Development of a tool for quantitative analysis of microsatellite mutations to evaluate pathogenesis and immunoediting in microsatellite unstable cancer